Search scope:
排序： Display mode:
Frontiers of Medicine Pages 907-923 doi: 10.1007/s11684-023-1009-7
Keywords： FAK6/7 SRRM4 neuroendocrine neoplasms pancreas breast
Paradoxical role of Id proteins in regulating tumorigenic potential of lymphoid cells
Sumedha Roy, Yuan Zhuang
Frontiers of Medicine 2018, Volume 12, Issue 4, Pages 374-386 doi: 10.1007/s11684-018-0652-x
A family of transcription factors known as Id proteins, or inhibitor of DNA binding and differentiation, is capable of regulating cell proliferation, survival and differentiation, and is often upregulated in multiple types of tumors. Due to their ability to promote self-renewal, Id proteins have been considered as oncogenes, and potential therapeutic targets in cancer models. On the contrary, certain Id proteins are reported to act as tumor suppressors in the development of Burkitt’s lymphoma in humans, and hepatosplenic and innate-like T cell lymphomas in mice. The contexts and mechanisms by which Id proteins can serve in such contradictory roles to determine tumor outcomes are still not well understood. In this review, we explore the roles of Id proteins in lymphocyte development and tumorigenesis, particularly with respect to inhibition of their canonical DNA binding partners known as E proteins. Transcriptional regulation by E proteins, and their antagonism by Id proteins, act as gatekeepers to ensure appropriate lymphocyte development at key checkpoints. We re-examine the derailment of these regulatory mechanisms in lymphocytes that facilitate tumor development. These mechanistic insights can allow better appreciation of the context-dependent roles of Id proteins in cancers and improve considerations for therapy.
Keywords： Id proteins lymphoma leukemia T cells B cells tumor suppressor oncogene
Title Author Date Type Operation
High frequency of alternative splicing variants of the oncogene in neuroendocrine tumors of the pancreas
Journal Article
京公网安备 11010502051620号
